Reliq Health Technologies - CEO Dr. Lisa Crossley
CEO Dr. Lisa Crossley
Source: Reliq Health Technologies
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Reliq Health Technologies (RHT) has signed a new sales partnership to access more than 500 physicians and 100,000 eligible patients
  • Reliq has also signed new contracts with two physician practices and a Rural Health Clinic (RHC) to add over 4,000 new patients in 2022
  • Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring
  • Reliq Health Technologies Inc. (RHT) opened trading at C$0.365 per share

Reliq Health Technologies (RHT) has signed a new sales partnership to access more than 500 physicians and 100,000 eligible patients in the U.S.

The company is also pleased to announce that it has signed new contracts with two physician practices and a Rural Health Clinic (RHC) to add over 4,000 new patients in 2022. Dr. Lisa Crossley, CEO at Reliq Health Technologies, commented on the news.

“We are pleased to be adding two new physician practices and a Rural Health Clinic as clients. These three clients are expected to add over 4,000 patients to our platform in 2022, at an average revenue of $50 per patient per month at 75 per cent gross margin. We are also very excited to have signed an agreement with a new sales partner who will give us access to over 500 physicians and more than 100,000 patients with eligible chronic conditions. This partnership is expected to greatly expand Reliq’s client base in the US Mountain and Pacific states.”

Dr. Crossley added,

“The company expects to add more than 20,000 patients to the platform over the next 12 months through this partnership, at an average revenue of $50 per patient per month (at 75 per cent gross margin). We have already begun onboarding patients for the first client acquired through this partnership. As previously disclosed, the Company expects the second half of 2022 to be a period of rapidly accelerating growth. Reliq remains on track to have over 100,000 patients on our iUGO Care platform by December 31, 2022.”

Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.

Reliq Health Technologies Inc. (RHT) opened trading at C$0.365 per share.

More From The Market Herald

" MCI Onehealth (TSX:DRDR) and Euclid Telehealth work to improve patient vision

MCI Onehealth (DRDR) and Euclid Telehealth are collaborating to increase access to care that can potentially prevent vision loss among Ontario patients.

" Spectral Medical (TSX:EDT) reports Q2 2022 results

Spectral Medical (EDT) released its financial results for the second quarter ended June 30, 2022.

" Hemostemix (TSXV:HEM) closes second tranche of non-brokered private placement

Hemostemix (HEM) has closed the second tranche of a non-brokered private placement of units for gross proceeds of $1,364,710.10.

" Nova Leap Health (TSXV:NLH) posts 2nd highest Q2 results in its history

Nova Leap Health (NLH) released its financial results for the quarter ended June 30, 2022.